D. Boral Capital Reiterates Buy Rating on Artelo Biosciences, Inc. (ARTL)
Tweet Send to a Friend
D. Boral Capital analyst Jason Kolbert reiterated a Buy rating and $20.00 price target on Artelo Biosciences, Inc. (NASDAQ: ARTL).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
